• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非结核分枝杆菌感染对肯尼亚小学生结核菌素检测结果的影响。

Effect of non-tuberculous Mycobacteria infection on tuberculin results among primary school children in Kenya.

作者信息

Kwamanga D O, Swai O B, Agwanda R, Githui W

机构信息

Respiratory Diseases Research Unit, Clinical Research Centre, Nairobi.

出版信息

East Afr Med J. 1995 Apr;72(4):222-7.

PMID:7621756
Abstract

Few tuberculosis studies carried out in Kenya since 1948 have reported on the variations of the occurrence and geographical distributions of non-tuberculous Mycobacteria infection. They have however not been able to clearly relate infection outcome to the use of tuberculin tests as epidemiologic and clinical tool. The present survey, conducted by Kenya Medical Research Institute in collaboration with the International Union Against Tuberculosis and Lung Diseases between 1986 and 1990 among school children aged 6-13 years in 18 randomly selected districts, investigated the following: the prevalence of sensitivity to tuberculin PPD RT 23 and PPD scrofulaceum RS 95 sensitin; geographic distribution of the reactions from the tests and; the influence of non-tuberculous Mycobacteria on the tuberculin results. The WHO cluster sampling procedures were used to select 30 schools in each of the 18 districts. Each child was tested with an intradermal dose of 2 TU of PPD RT 23 with Tween 80 (PPD RT 23) on the right hand and 2 TU of PPD Scrofulaceum RS 95 sensitin with tween 80 (PPD RS 95) on the left hand. The results were read after 72 hours of testing. A total of 1015 BCG scar negative children was included in the survey. Of these, 981 were tested and read. Over 47% of the children did not react to both antigens while 6.1% and 22.7% reacted to human type tuberculin and environmental sensitin respectively. There was cross reaction between the two tests in 23.8% of the children from low altitude area who had more and larger reaction to the tests than the middle and higher altitude regions of the country.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

自1948年以来,在肯尼亚开展的结核病研究中,很少有报告提及非结核分枝杆菌感染的发生率及地理分布的变化情况。然而,这些研究未能明确将感染结果与结核菌素试验作为流行病学和临床工具的使用联系起来。本次调查由肯尼亚医学研究所与国际防痨和肺部疾病联盟合作,于1986年至1990年期间,在18个随机选取地区的6至13岁学童中进行,调查了以下内容:对结核菌素PPD RT 23和PPD scrofulaceum RS 95变应原的敏感性患病率;试验反应的地理分布;以及非结核分枝杆菌对结核菌素结果的影响。采用世界卫生组织整群抽样程序,在18个地区各选取30所学校。每个孩子右手皮内注射2 TU含吐温80的PPD RT 23(PPD RT 23),左手皮内注射2 TU含吐温80的PPD Scrofulaceum RS 95变应原(PPD RS 95)。测试72小时后读取结果。共有1015名卡介苗接种疤痕阴性儿童纳入调查。其中,981名儿童接受了测试和结果读取。超过47%的儿童对两种抗原均无反应,而分别有6.1%和22.7%的儿童对人型结核菌素和环境变应原产生反应。来自低海拔地区的儿童中有23.8%出现两种试验间的交叉反应,这些儿童比该国中高海拔地区的儿童对试验的反应更多、更大。(摘要截选至250词)

相似文献

1
Effect of non-tuberculous Mycobacteria infection on tuberculin results among primary school children in Kenya.非结核分枝杆菌感染对肯尼亚小学生结核菌素检测结果的影响。
East Afr Med J. 1995 Apr;72(4):222-7.
2
A comparison of dual skin test with mycobacterial antigens and tuberculin skin test alone in estimating prevalence of Mycobacterium tuberculosis infection from population surveys.在人群调查中,比较使用分枝杆菌抗原的双重皮肤试验与单独使用结核菌素皮肤试验来评估结核分枝杆菌感染率。
Int J Tuberc Lung Dis. 2003 Apr;7(4):312-9.
3
National tuberculin survey of Kenya, 1986-1990.1986 - 1990年肯尼亚全国结核菌素调查
Int J Tuberc Lung Dis. 1998 Apr;2(4):272-80.
4
Comparative testing of skin reactions to PPD mycobacterins from Mycobacterium tuberculosis and Mycobacterium scrofulaceum in school-age children.学龄儿童对结核分枝杆菌和瘰疬分枝杆菌的纯蛋白衍生物(PPD)菌素皮肤反应的对比测试。
J Hyg Epidemiol Microbiol Immunol. 1984;29(3):275-81.
5
Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States.美国医护人员和医学生对结核分枝杆菌纯蛋白衍生物及鸟分枝杆菌敏感原的皮肤试验反应
Int J Tuberc Lung Dis. 2001 Dec;5(12):1122-8.
6
Density of tuberculin skin reaction and its association with tuberculosis infection as defined by dual tuberculin testing.结核菌素皮肤反应的密度及其与双重结核菌素检测所定义的结核感染的关联。
Int J Tuberc Lung Dis. 2000 Nov;4(11):1060-5.
7
Sensitivity to mycobacterial antigens.对分枝杆菌抗原的敏感性。
Bull World Health Organ. 1974;51(3):279-82.
8
Dual intradermal testing of Barbadian children with tuberculin and Battey bacillus antigen.对巴巴多斯儿童进行结核菌素和巴氏杆菌抗原的双重皮内试验。
West Indian Med J. 1982 Dec;31(4):198-204.
9
Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users.在现注射吸毒者和既往注射吸毒者中使用双分枝杆菌抗原的结核菌素皮肤试验与QuantiFERON-TB检测之间的一致性。
Med Sci Monit. 2006 Apr;12(4):MT11-6. Epub 2006 Mar 28.
10
[Prevalence of mycobacterial infection in school children of Rio de Janeiro city (author's transl)].里约热内卢市学童分枝杆菌感染的患病率(作者译)
Rev Bras Pesqui Med Biol. 1978 Dec;11(6):337-44.

引用本文的文献

1
Cracking the antigenic code of mycobacteria: CFP-10/ESAT-6 tuberculosis skin test and misleading results.破解分枝杆菌的抗原密码:CFP-10/ESAT-6结核菌素皮肤试验及误导性结果。
J Clin Tuberc Other Mycobact Dis. 2024 Apr 2;36:100436. doi: 10.1016/j.jctube.2024.100436. eCollection 2024 Aug.
2
Detection of DNA in CD34 peripheral blood mononuclear cells of Ugandan adults with latent infection: a cross-sectional and nested prospective study.乌干达成年潜伏感染者CD34⁺外周血单个核细胞中DNA的检测:一项横断面和巢式前瞻性研究。
AAS Open Res. 2020 Jul 29;3:34. doi: 10.12688/aasopenres.13108.1. eCollection 2020.
3
Diagnosis of latent tuberculosis: Can we do better?
诊断潜伏性结核病:我们能否做得更好?
Ann Thorac Med. 2009 Jan;4(1):5-9. doi: 10.4103/1817-1737.44778.
4
Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.对疑似活动性肺结核的人类免疫缺陷病毒(HIV)感染者中差异区域1(RD1)表位的反应:一项试点研究。
Clin Exp Immunol. 2007 Oct;150(1):91-8. doi: 10.1111/j.1365-2249.2007.03462.x. Epub 2007 Aug 3.
5
Health impacts of environmental mycobacteria.环境分枝杆菌对健康的影响。
Clin Microbiol Rev. 2004 Jan;17(1):98-106. doi: 10.1128/CMR.17.1.98-106.2004.